Value of Laparoscopic Microwave Coagulation Therapy for Hepatocellular Carcinoma in Relation to Tumor Size and Location

 

 Buy Article Permissions and Reprints

Background and Study Aims: The indications for laparoscopic microwave coagulation therapy (LMCT) for hepatocellular carcinoma (HCC) have not yet been adequately evaluated. This study investigated the value of LMCT in the treatment of HCC.

Patients and Methods: Forty-three patients with liver cirrhosis (including five patients in Child- Pugh grade C), with 56 HCC lesions, were enrolled in the study. When dynamic computed tomography (CT) showed a loss in HCC enhancement characteristics and a low concentration area after LMCT, a lesion was judged to have undergone complete necrosis.

Results: The rate of complete necrosis for lesions measuring 40 mm or less was significantly higher (P < 0.01) than for those measuring 41 mm or more. The rate of complete necrosis for lesions located on the liver surface, excluding those located close to the gallbladder or in contact with the diaphragm, was also significantly higher (P < 0.01) than for those situated deep within the liver. The outcome for lesions of 40 mm or less was favorable. Intra-abdominal hemorrhage occurred in two patients, pneumothorax in three, and hepatic infarction in one, all associated with LMCT. However, these patients did not suffer any sequelae of clinical significance.

Conclusions: This study suggests that there is a strong indication for LMCT for HCCs measuring 40 mm or less in diameter and those located on the liver surface even if they are as large as 50 mm, but not for those located close to the gallbladder or in contact with the diaphragm. LMCT appears to be applicable in patients with impaired liver function.

References

• 1 Nagasue N, Yukaya H, Ogawa Y, et al. Clinical experience with 118 hepatic resections for hepatocellular carcinoma.  Surgery. 1986;  99 694-701
  PubMedGoogle Scholar
• 2 Shiina S, Tagawa K, Niwa Y, et al. Percutaneous ethanol injection therapy for hepatocellular carcinoma: result in 146 patients.  Am J Roentgenol. 1993;  160 1023-1028
  PubMedGoogle Scholar
• 3 Ishii H, Okada S, Nose H, et al. Local recurrence of hepatocellular carcinoma after percutaneous ethanol injection.  Cancer. 1996;  77 1792-1796
  CrossrefPubMedGoogle Scholar
• 4 Ebara M, Fukuda H, Yoshikawa M, et al. Percutaneous ethanol injection (PEI) for patients with hepatocellular carcinoma 3 cm or smaller [in Japanese with English abstract].  Endosc Dig. 1997;  9 1315-1320
  PubMedGoogle Scholar
• 5 Shiina S, Tagawa K, Unuma T, et al. Percutaneous ethanol injection for hepatocellular carcinoma: a histopathologic study.  Cancer. 1991;  68 1524-1530
  PubMedGoogle Scholar
• 6 Ohnishi K, Yoshioka H, Ito S, Fujiwara K. Prospective randomized controlled trial comparing percutaneous acetic acid injection and ethanol injection for small hepatocellular carcinoma.  Hepatology. 1998;  27 67-72
  CrossrefPubMedGoogle Scholar
• 7 Kuroda C, Sakurai M, Monden M. Limitation of transcatheter arterial chemoembolization using iodized oil for small hepatocellular carcinoma: a study in resected cases.  Cancer. 1991;  67 81-86
  CrossrefPubMedGoogle Scholar
• 8 Saitsu H, Utsunomiya T, Emi Y, et al. Microwave coagulation therapy [in Japanese with English abstract].  Endosc Dig. 1997;  9 1349-1354
  PubMedGoogle Scholar
• 9 Saitsu H, Yoshida M, Taniwaki S, et al. Laparoscopic coagulo-necrotic therapy using microtase for small hepatocellular carcinoma [in Japanese with English abstract].  Nippon Shokakibyo Gakkai Zasshi (Jpn J Gastroenterol). 1991;  88 2727
  PubMedGoogle Scholar
• 10 Watanabe Y, Sato M, Abe Y. Laparoscopic microwave coagulation therapy for hepatocellular carcinoma: a feasible study of an alternative option for poor-risk patients.  J Laparoscopic Surg. 1995;  5 169-175
  PubMedGoogle Scholar
• 11 Sato M, Watanabe Y, Ueda S, et al. Microwave coagulation therapy for hepatocellular carcinoma.  Gastroenterology. 1996;  110 1507-1514
  CrossrefPubMedGoogle Scholar
• 12 Yamanaka N, Okamoto E, Tanaka T, et al. Laparoscopic microwave coagulation therapy for hepatocellular carcinoma.  Surg Laparosc Endosc. 1995;  5 444-449
  PubMedGoogle Scholar
• 13 Ido K, Isoda N, Kawamoto C, et al. Laparoscopic microwave coagulation for solitary hepatocellular carcinoma performed under laparoscopic ultrasonography.  Gastrointest Endosc. 1997;  45 415-420
  PubMedGoogle Scholar
• 14 Seki T, Wakabayashi M, Nakagawa T, et al. Ultrasonically guided percutaneous microwave coagulation therapy for small hepatocellular carcinoma.  Cancer. 1994;  74 817-825
  CrossrefPubMedGoogle Scholar
• 15 Murakami F, Yoshimatsu S, Yamashita Y, et al. Treatment of hepatocellular carcinoma: value of percutaneous microwave coagulation.  AJR Am J Roentgenol. 1994;  164 1159-1164
  PubMedGoogle Scholar
• 16 Saitsu H, Nakayama T, Isomura T, et al. New endoscopic surgical treatment: thoracoscopic microwave coagulo-necrotic therapy for small hepatocellular carcinoma [in Japanese with English abstract].  J Microwave Surg. 1994;  12 1-8
  PubMedGoogle Scholar
• 17 Couinaud C. Les enveloppes vasculo-biliaires du foie ou capsule de Glisson.  Lyon Chir. 1954;  49 489-607
  PubMedGoogle Scholar
• 18 Beppu T, Ogawa M, Matsuda T, et al. Efficacy of microwave coagulation therapy (MCT) in patients with liver cirrhosis [in Japanese with English abstract].  Jpn J Cancer Chemother. 1998;  25 1358-1361
  PubMedGoogle Scholar
• 19 Matsui O, Kadoya M, Yoshikawa J, et al. Small hepatocellular carcinoma treatment with subsegmental transcatheter arterial embolization.  Radiology. 1993;  188 79-83
  PubMedGoogle Scholar
• 20 Watanabe M, Ichida T, Sato T. Recurrence of hepatocellular carcinoma after segmental LP-TAE [in Japanese].  Kan Tan Sui. 1995;  31 239-249
  PubMedGoogle Scholar
• 21 Asahara T, Katayama K, Itamoto T, et al. Thoracoscopic microwave coagulation therapy for hepatocellular carcinoma.  Hiroshima J Med Sci. 1998;  47 125-131
  PubMedGoogle Scholar
• 22 Zhou XD, Tang ZY, Yu YQ, et al. Microwave surgery in the treatment of hepatocellular carcinoma.  Semin Surg Oncol. 1993;  9 318-322
  PubMedGoogle Scholar

H. Shinzawa

Second Dept. of Internal Medicine Yamagata University School of Medicine

PN 990-9585 2-2-2 Iida Nishi

Yamagata City, Japan

Phone: +81-23-628-5311

Email: hsinzawa@med.id.yamagata-u.ac.jp